116.35
price up icon0.08%   0.09
after-market アフターアワーズ: 116.52 0.17 +0.15%
loading
前日終値:
$116.26
開ける:
$115.71
24時間の取引高:
13.22M
Relative Volume:
1.49
時価総額:
$202.32B
収益:
$44.33B
当期純損益:
$6.50B
株価収益率:
31.30
EPS:
3.717
ネットキャッシュフロー:
$7.40B
1週間 パフォーマンス:
+3.69%
1か月 パフォーマンス:
+7.46%
6か月 パフォーマンス:
-11.49%
1年 パフォーマンス:
-14.37%
1日の値動き範囲:
Value
$115.49
$116.81
1週間の範囲:
Value
$112.05
$116.81
52週間の値動き範囲:
Value
$105.27
$140.84

Abbott Laboratories Stock (ABT) Company Profile

Name
名前
Abbott Laboratories
Name
セクター
Healthcare (1111)
Name
電話
(224) 667-6100
Name
住所
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
Name
職員
114,000
Name
Twitter
@AbbottNews
Name
次回の収益日
2026-01-22
Name
最新のSEC提出書
Name
ABT's Discussions on Twitter

Compare ABT vs SYK, MDT, BSX, EW

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Medical Devices icon
ABT
Abbott Laboratories
116.35 202.16B 44.33B 6.50B 7.40B 3.717
Medical Devices icon
SYK
Stryker Corp
387.46 147.74B 25.12B 3.25B 4.28B 8.3984
Medical Devices icon
MDT
Medtronic Plc
97.66 124.39B 35.48B 4.64B 5.41B 3.582
Medical Devices icon
BSX
Boston Scientific Corp
76.85 112.40B 20.08B 2.89B 3.66B 1.9391
Medical Devices icon
EW
Edwards Lifesciences Corp
86.47 49.85B 6.07B 1.06B 799.60M 1.8527

Abbott Laboratories Stock (ABT) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-10-10 開始されました The Benchmark Company Buy
2025-07-18 アップグレード Jefferies Hold → Buy
2025-06-16 開始されました Leerink Partners Market Perform
2024-10-08 開始されました Oppenheimer Outperform
2024-09-19 開始されました Piper Sandler Overweight
2024-07-30 ダウングレード Edward Jones Buy → Hold
2024-05-30 開始されました Goldman Buy
2023-07-21 アップグレード Wolfe Research Underperform → Peer Perform
2023-05-30 ダウングレード Morgan Stanley Overweight → Equal-Weight
2023-04-20 繰り返されました Barclays Overweight
2023-04-20 繰り返されました Bernstein Outperform
2023-04-20 繰り返されました JP Morgan Overweight
2023-04-20 繰り返されました Raymond James Outperform
2023-04-20 繰り返されました UBS Buy
2023-04-20 繰り返されました Wolfe Research Underperform
2023-03-29 開始されました UBS Buy
2022-10-26 開始されました Mizuho Neutral
2022-10-18 開始されました Barclays Overweight
2022-10-12 開始されました Jefferies Hold
2022-07-06 開始されました Wolfe Research Underperform
2022-03-02 再開されました BofA Securities Buy
2022-01-27 繰り返されました Credit Suisse Outperform
2022-01-27 繰り返されました Morgan Stanley Overweight
2022-01-27 繰り返されました Raymond James Outperform
2022-01-27 繰り返されました UBS Buy
2021-12-10 開始されました RBC Capital Mkts Outperform
2021-10-27 アップグレード Atlantic Equities Neutral → Overweight
2021-10-14 開始されました Redburn Neutral
2021-05-25 開始されました Barclays Overweight
2021-04-15 開始されました Atlantic Equities Neutral
2021-01-28 アップグレード BTIG Research Neutral → Buy
2020-09-11 開始されました Wolfe Research Outperform
2020-06-01 ダウングレード Goldman Neutral → Sell
2020-03-05 開始されました Citigroup Buy
2020-02-13 開始されました Goldman Neutral
2020-02-06 再開されました BTIG Research Neutral
2020-01-02 ダウングレード Guggenheim Buy → Neutral
2019-06-13 繰り返されました BofA/Merrill Buy
2019-02-07 繰り返されました BofA/Merrill Buy
2019-01-02 ダウングレード Citigroup Neutral → Sell
2018-11-30 アップグレード Goldman Neutral → Buy
2018-10-16 開始されました Barclays Overweight
2018-06-27 開始されました Bernstein Outperform
2018-01-30 繰り返されました Citigroup Neutral
2018-01-25 繰り返されました Stifel Buy
2018-01-25 アップグレード William Blair Mkt Perform → Outperform
2018-01-03 開始されました Evercore ISI Outperform
2018-01-02 アップグレード JP Morgan Neutral → Overweight
2018-01-02 アップグレード Morgan Stanley Equal-Weight → Overweight
2017-10-19 繰り返されました RBC Capital Mkts Outperform
2017-10-19 繰り返されました Stifel Buy
すべてを表示

Abbott Laboratories (ABT) 最新ニュース

pulisher
Feb 27, 2026

Xponance Inc. Sells 31,276 Shares of Abbott Laboratories $ABT - MarketBeat

Feb 27, 2026
pulisher
Feb 27, 2026

Primecap Management Co. CA Sells 65,100 Shares of Abbott Laboratories $ABT - MarketBeat

Feb 27, 2026
pulisher
Feb 27, 2026

Abbott Laboratories $ABT Shares Sold by Erste Asset Management GmbH - MarketBeat

Feb 27, 2026
pulisher
Feb 26, 2026

Abbott Laboratories (ABT) Announces $20 Billion Senior Notes Off - GuruFocus

Feb 26, 2026
pulisher
Feb 26, 2026

Abbott Laboratories Announces $20 Billion Senior Notes Offering - Global Legal Chronicle

Feb 26, 2026
pulisher
Feb 26, 2026

Abbott Laboratories Prices $20 Billion Senior Notes Offering - TipRanks

Feb 26, 2026
pulisher
Feb 26, 2026

Abbott takes out M&A whopper amid drugs binge - GlobalCapital

Feb 26, 2026
pulisher
Feb 26, 2026

Abbott Prices $20 Billion Multi-Tranche Notes to Fund Exact Sciences Deal - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

Assessing Abbott Laboratories (ABT) Valuation After Mixed Share Performance And Conflicting Fair Value Signals - Yahoo Finance

Feb 26, 2026
pulisher
Feb 26, 2026

VivaVision Eyes Hong Kong Listing Before Cash Coffers Dry Up - Benzinga

Feb 26, 2026
pulisher
Feb 26, 2026

Intuitive Surgical or Abbott: Which MedTech Stock Is a Better Bet Now? - Nasdaq

Feb 26, 2026
pulisher
Feb 26, 2026

Abbott’s US$20b Bond Bet Recasts Growth Story In Oncology Diagnostics - simplywall.st

Feb 26, 2026
pulisher
Feb 26, 2026

US Bancorp DE Sells 37,572 Shares of Abbott Laboratories $ABT - MarketBeat

Feb 26, 2026
pulisher
Feb 26, 2026

Abbott's Meltdown Is Worth Buying, Compelling, Profitable Growth Prospects - Seeking Alpha

Feb 26, 2026
pulisher
Feb 26, 2026

Precision Medicine Market 2026–2031 Growth: 13%+ CAGR as AI Integration and Biomarker Advancements Drive Adoption, Reports Mordor Intelligence - GlobeNewswire Inc.

Feb 26, 2026
pulisher
Feb 26, 2026

Pre-market: ABT.SW Abbott Laboratories (SIX) -12.00% to CHF88.00: watch CHF85.00 - Meyka

Feb 26, 2026
pulisher
Feb 25, 2026

Abbott India: Quiet Rally In A Noisy MarketWhat US Investors Miss - AD HOC NEWS

Feb 25, 2026
pulisher
Feb 25, 2026

Forget Tilray: This Steady Income Stock Beats Wild Cannabis Swings Every Time - AOL.com

Feb 25, 2026
pulisher
Feb 25, 2026

Is Abbott Laboratories Stock Underperforming the Nasdaq? - Yahoo Finance

Feb 25, 2026
pulisher
Feb 25, 2026

How The Evolving Wall Street Narrative Is Reframing Abbott Laboratories (ABT) Valuation Prospects - Yahoo Finance

Feb 25, 2026
pulisher
Feb 24, 2026

Abbott Laboratories Secures Major Bond Issue to Fund Strategic Acquisition - AD HOC NEWS

Feb 24, 2026
pulisher
Feb 24, 2026

Wrongful Death Case Tests Abbott’s FreeStyle Libre 3 Risk Oversight - simplywall.st

Feb 24, 2026
pulisher
Feb 24, 2026

Abbott Laboratories Advances Major Acquisition Amid Market Scrutiny - AD HOC NEWS

Feb 24, 2026
pulisher
Feb 24, 2026

Vestmark Advisory Solutions Inc. Cuts Stock Position in Abbott Laboratories $ABT - MarketBeat

Feb 24, 2026
pulisher
Feb 24, 2026

Shanghai Henlius Biotech Expands Abbott License for HANSIZHUANG, Terminates KGBio Territories – Key Amendments and Market Impact 1234 - Minichart

Feb 24, 2026
pulisher
Feb 24, 2026

Point of Care Diagnostics Market Competitive Landscape - GlobeNewswire

Feb 24, 2026
pulisher
Feb 24, 2026

Point of Care Diagnostics Market Competitive Landscape Report 2025 Featuring Top 5 PlayersSysmex, Abbott Laboratories, Becton Dickinson and Co, Danaher, Quidel Diagnostics - Yahoo Finance

Feb 24, 2026
pulisher
Feb 24, 2026

Exact Sciences shareholders give nod for acquisition by Abbott - Medical Buyer

Feb 24, 2026
pulisher
Feb 24, 2026

Cardiac Marker Testing Market Is Going to Boom |• Abbott • Roche - openPR.com

Feb 24, 2026
pulisher
Feb 24, 2026

Dakota Wealth Management Has $27.16 Million Stock Holdings in Abbott Laboratories $ABT - MarketBeat

Feb 24, 2026
pulisher
Feb 24, 2026

Is Abbott Laboratories (ABT) Pricing Reflect Long Term Value After Recent Share Price Weakness - Yahoo Finance

Feb 24, 2026
pulisher
Feb 23, 2026

Abbott Laboratories Launches Landmark $20 Billion Bond Offering - AD HOC NEWS

Feb 23, 2026
pulisher
Feb 23, 2026

ABT.SW Abbott Laboratories (SIX) down 13.50% pre-market: CHF86.50 support to watch - Meyka

Feb 23, 2026
pulisher
Feb 23, 2026

Abbott (ABT) Ascends While Market Falls: Some Facts to Note - Nasdaq

Feb 23, 2026
pulisher
Feb 23, 2026

Abbott Labs: A boring dividend machine that could quietly make you rich - MSN

Feb 23, 2026
pulisher
Feb 23, 2026

Abbott Laboratories Kicks Off Bond Sale for Exact Sciences Deal - Bloomberg.com

Feb 23, 2026
pulisher
Feb 23, 2026

Abbott Laboratories (ABT) Likely to Benefit From Nutrition Segment Recovery - Insider Monkey

Feb 23, 2026
pulisher
Feb 23, 2026

Abbott Labs: A Boring Dividend Machine That Could Quietly Make You Rich - AOL.com

Feb 23, 2026
pulisher
Feb 23, 2026

Key facts: Abbott Laboratories to raise $20 billion via bond sale; files for notes offering - TradingView

Feb 23, 2026
pulisher
Feb 23, 2026

A Look At Abbott Laboratories (ABT) Valuation After Recent Share Price Moves - simplywall.st

Feb 23, 2026
pulisher
Feb 23, 2026

Abbott Laboratories (ABT) Investor Outlook: Exploring A Promising 18.87% Potential Upside - DirectorsTalk Interviews

Feb 23, 2026
pulisher
Feb 23, 2026

Abbott lines up one of the year's biggest bond sales at $20B - Crain's Chicago Business

Feb 23, 2026
pulisher
Feb 23, 2026

Abbott Laboratories Stock (ABT) Opinions on Exact Sciences Acquisition - Quiver Quantitative

Feb 23, 2026
pulisher
Feb 23, 2026

Abbott Laboratories (ABT) Plans $20B Bond Sale to Fund Exact Sci - GuruFocus

Feb 23, 2026
pulisher
Feb 23, 2026

Exact Sciences Stockholders Approve Abbott Merger as Executive Pay Proposal Fails at Special Meeting - Yahoo Finance

Feb 23, 2026
pulisher
Feb 23, 2026

Abbott Laboratories (ABT) Stock Price, Trades & News - GuruFocus

Feb 23, 2026
pulisher
Feb 23, 2026

Abbott kicks off bond sale for Exact Sciences deal - Modern Healthcare News

Feb 23, 2026
pulisher
Feb 23, 2026

Abbott (ABT) Submits Automatic Mixed Securities Shelf Filing - GuruFocus

Feb 23, 2026
pulisher
Feb 23, 2026

Abbott seeks $20 billion in US bond sale for Exact Sciences dealBloomberg News - marketscreener.com

Feb 23, 2026
pulisher
Feb 23, 2026

Abbott files for eight-part notes offering, size not disclosedSEC filing - marketscreener.com

Feb 23, 2026
pulisher
Feb 23, 2026

Abbott Labs Commences 8-Part Bond Sale Tied to Exact Sciences Acquisition - marketscreener.com

Feb 23, 2026

Abbott Laboratories (ABT) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
medical_devices SYK
$387.46
price up icon 0.36%
medical_devices MDT
$97.66
price up icon 0.65%
medical_devices BSX
$76.85
price up icon 1.45%
medical_devices EW
$86.47
price up icon 0.66%
$84.27
price up icon 0.42%
大文字化:     |  ボリューム (24 時間):